Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.
- NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.
- NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_assertion evidence source_evidence_literature NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.
- NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_assertion SIO_000772 18602826 NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.
- NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_assertion wasDerivedFrom befree-20150227 NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.
- NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_assertion wasGeneratedBy ECO_0000203 NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP267571.RAQMJv_-1N75ZH-gur6b_Ul4x0e8XYu27VZBtmbPOdxh8130_provenance.